NASDAQ · SERVICES-HELP SUPPLY SERVICES · MID CAP
Cross Country Healthcare, Inc. CCRN
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.1B
▼ 21.6% vs FY2024
EPS · FY25
$-2.93
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-25.6%
Net margin · FY25
-9.0%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.1B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 9 cents on every revenue dollar this year.
Per share
USD -2.93
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-25.6%
Return on equity, FY2025
ROE
Operating margin-8.0%
Net margin-9.0%
Return on assets-18.3%
Each USD of equity lost 26 cents this year.
Returned to shareholders
USD 6.8M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 6.8M
Share of profit-7.2%
Consecutive raises—
USD 6.8M in buybacks went back to shareholders in a year without profit.
Growth
+4.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−27.8%
+4.7%
+3.2%
+6.6%
Returned to shareholders
−42.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years−12.3%
Change, 10 years−0.7%
The share count shrank 12% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 449.0M
total assets, end of FY2025
Total assetsUSD 449.0M
EquityUSD 322.8M
CashUSD 108.7M
Current ratio3.78×
Equity funds 72% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
1.1
1.3
2.0
2.8
1.7
0.8
0.8
0.8
0.9
0.8
0.8
0.6
0.4
0.4
0.4
0.4
0.6
Operating income $B
−0.1
−0.0
0.1
0.3
0.1
−0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
0.0
EBITDA $B
−0.1
0.0
0.1
0.3
0.1
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
Income tax $B
0.0
−0.0
0.0
0.1
0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
Net income $B
−0.1
−0.0
0.1
0.2
0.1
−0.0
−0.1
−0.0
0.0
0.0
0.0
−0.0
−0.1
−0.0
0.0
−0.0
0.0
EPS, diluted $
−2.93
−0.44
2.05
4.95
3.53
−0.36
−1.61
−0.48
1.01
0.15
0.14
−1.02
−1.68
−1.37
0.13
−0.09
0.22
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−25.6
−3.3
15.8
50.5
58.8
−8.2
−30.4
−7.5
19.3
5.5
3.3
−21.9
−28.1
−18.4
1.7
−1.1
2.7
Shares out B
0.03
0.03
0.03
0.04
0.04
0.04
0.04
0.04
0.04
0.03
0.03
0.03
0.03
0.03
0.03
0.03
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed